Presentation is loading. Please wait.

Presentation is loading. Please wait.

Primary ESRD Modality in New ESRD Patients, 1995-97* New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1.

Similar presentations


Presentation on theme: "Primary ESRD Modality in New ESRD Patients, 1995-97* New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1."— Presentation transcript:

1 Primary ESRD Modality in New ESRD Patients, 1995-97* New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1

2 Demographic Characteristics of New ESRD Patients, 1997* *Reported on HCFA Medical Evidence Form **Primary/contributing cause of ESRD USRDS 1999 IV -2 Average Age % Male % Diabetes** New Patients (Age or %)

3 Reported Race and Hispanic Ethnicity among New ESRD Patients, 1997* New Patients (%) *Reported on HCFA Medical Evidence Form Unknown race is not included in percentages. Approximately 0.6% of patients reported race as “Unknown”. Number of People White Black Asian / Native American / Other Pacific Islander Alaskan Native USRDS 1999 IV -3 Middle Indian Other/ East Subcontinent Multicultural

4 Diabetes Hyper- Glomerulo- Secondary Interstitial Cystic/ Neoplasms / Miscel- tension nephritis GN/ Vascu- Nephritis Hereditary/ Tumors laneous litis Pyelo - Congenital Nephritis Primary Detailed Disease Groups Reported among New ESRD Patients, 1997* New Patients (%) USRDS 1999 IV - 4 *Reported on HCFA Medical Evidence Form

5 Diabetes Hypertension Glomerulo- Cystic Other Causes nephritis Kidney Disease Primary Disease Reported among New ESRD Patients by Year, 1995-97* *Reported on HCFA Medical Evidence Form New Patients (%) USRDS 1999 IV -5

6 Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* *Reported on HCFA Medical Evidence Form Congestive CAD MI Cardiac CVD / Peripheral Heart Arrest CVA/ Vascular Failure TIA Disease New Patients (%) USRDS 1999 IV -6

7 New Patients (%) Gender Diabetes Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Gender and Diabetes in New Dialysis Patients, 1997* *Reported on HCFA Medical Evidence Form USRDS 1999 IV -7 Male Female Yes No

8 Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Age for New Dialysis Patients, 1997* New Patients (%) *Reported on HCFA Medical Evidence Form Age USRDS 1999 IV -8 20-44 45-64 65-74 75+

9 New Patients (%) Ischemic Heart Disease (CAD) and Myocardial Infarction (MI) by Race and Hispanic Ethnicity in New Dialysis Patients, 1997* *Reported on HCFA Medical Evidence Form White Black Asian Native Other Hispanic Non- American Hispanic USRDS 1999 IV -9

10 Non-Cardiovascular Patient Characteristics among New Dialysis Patients, 1997* Diabetes COPD Cancer Smoker Inability to Inability to on insulin Ambulate Transfer *Reported on HCFA Medical Evidence Form New Patients (%) USRDS 1999 IV -10

11 Serum Albumin and Body Mass Index (BMI) for New ESRD Patients, 1995-98* 1995 1996 1997 1998 1995 1996 1997 1998 Average Serum Albumin (g/dl) Average BMI (kg/m 2 ) *Reported on HCFA Medical Evidence Form; 1998 data are through June USRDS 1999 IV -11

12 Distribution of Facilities by Average Number of Comorbidities Reported per Patient, 1995-97* Average Number of Comorbidities Reported Facilities (%) *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years USRDS 1999 IV -12 0 <1 1 to <2 2 to <3 3 to <4 4 to <5 5 to <6

13 Distribution of Facilities by Percent of Patients with Zero Comorbidities Reported, 1995-97* Facilities (%) Percent of Patients with Zero Comorbidities Reported *Reported on HCFA Medical Evidence Form **Excludes facilities with < 5 new patients in 3 years USRDS 1999 IV -13

14 20-44 45-64 65-74 75+ Serum Creatinine and GFR for New ESRD Patients by Age Group, 1995-97* *Reported on HCFA Medical Evidence Form **MDRD Formula Age Average Serum Creatinine (mg/dl)Average GFR (ml/min)** USRDS 1999 IV -14

15 Serum Creatinine and Weight for New ESRD Patients by Year, 1995-98* Average Serum Creatinine (mg/dl) Average Weight (kg) USRDS 1999 IV -15 *Reported on HCFA Medical Evidence Form; 1998 data are through June 1995 1996 1997 1998 1995 1996 1997 1998

16 EPO Use Before ESRD by Age and Gender for New ESRD Patients, 1995-97* Receiving EPO Before ESRD (%) *Reported on HCFA Medical Evidence Form AgeGender USRDS 1999 IV -16 20-44 45-64 65-74 75+ Female Male

17 EPO Use Before ESRD for New ESRD Patients by Race and Hispanic Ethnicity, 1995-97* Receiving EPO Before ESRD (%) *Reported on HCFA Medical Evidence Form White Black Asian Native Other Hispanic Non- American Hispanic USRDS 1999 IV -17

18 Employed ** Unemployed Retired, Retired Homemaker Medical Student Disabled by Age Leave Prior vs. Current Employment among New ESRD Patients, Ages 20-64, 1997* *Reported on HCFA Medical Evidence Form. **Includes part-time and full-time. Patients with employment status missing are excluded. New Patients (%) USRDS 1999 IV -18 6 months before ESRD (missing = 10%) At onset of ESRD (missing = 4%)


Download ppt "Primary ESRD Modality in New ESRD Patients, 1995-97* New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1."

Similar presentations


Ads by Google